Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity
Key Points. Reduced PRC2 function in T-ALL is associated with asparaginase resistance that is linked to reduced WNT/STOP pathway activity.Asparaginase resi
Great to see this out, collaboration with the Bond lab @sysbioire.bsky.social to understand consequences of EZH2 mutation in T-acute lymphoblastic leukaemia (T-ALL). Congrats to @lefeivret.bsky.social @cosmintudose.bsky.social and other authors not on bluesky!
ashpublications.org/bloodadvance...
05.12.2025 11:15 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0
Finally, thanks to @researchireland.ie, CRT Genomics Data science for funding this work! And thanks to @ucddublin.bsky.social @sysbioire.bsky.social for the support offered! 17/17
09.09.2025 13:30 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Thanks to my supervisors for guiding this work Jonathan Bond and @colmr.bsky.social and to everyone involved for all the important and hard work put in Luke Jones, Claire Fitzgerald, @tgrosu.bsky.social, @nmaziak.bsky.social Rebecca Ling, @roylab-oxford.bsky.social, @vaquerizasjm.bsky.social 16/17
09.09.2025 13:30 โ ๐ 2 ๐ 0 ๐ฌ 1 ๐ 0
...leading to partial activation of an onco-fetal LIN28B-driven program that makes AML cells more resistant to CDK6 inhibition. 15/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Our work highlights the role of polycomb in guiding the expression of lineage-defining transcriptional programs and heterozygous loss of EZH2 is enough to blur the lines between transcriptional programsโฆ๐ซ๏ธ14/17
09.09.2025 13:30 โ ๐ 1 ๐ 0 ๐ฌ 1 ๐ 0
Finally, we found that the EZH2-LIN28B-CDK6 axis leads to increased resistance to the CDK4/6 inhibitor palbociclib. 13/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
LIN28B is rarely expressed in normal adult cells, but is active in >20 cancer types, including leukemias. As part of this program we find the cyclin-dependent kinase CDK6, which shows decreased promoter H3K27me3, accompanied by increased H3K27ac and increased transcription. 12/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Finally, we found that our EZH2+/- cells show activation of an alternative lineage transcriptomic program associated with LIN28B activation. Using RNA-seq from LIN28B-KD CD34+ fetal liver cells, we confirmed that EZH2-depleted cells are consistent with LIN28B activation. 11/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Notably, we observed a compartmentalization change upstream of the LIN28B locus in the Hi-C data. While this locus did not show any significant change in H3K27me or H3K27ac, the LIN28B fetal oncogene was upregulated in our EZH2+/- cells. 10/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Secondly, as observed in the Hi-C, these peaks are found in regions where there is high DNA-DNA contact frequency in all conditions, suggesting H3K27me3 is preferentially maintained at these hubs of compacted chromatin โฐโฐโฐ. 9/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Naturally, we observed that some level of H3K27me3 is maintained in EZH2+/- and we found out that these maintained me3 peaks show distinctive characteristics. Firstly, these peaks are wider, covering a larger genomic area๐งฌ. 8/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Again, we observed that regions with increased accessibility were enriched for GO terms relating to cell differentiation and alternative transcriptional lineages. 6/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
As expected, we observed genome-wide decrease in the PRC2-mark H3K27me3, accompanied by increased H3K27ac and increased chromatin accessibility. NOTE: C5 and C9 are EZH2+/- cells in the figure below. 5/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
This suggests that PRC2 depletion leads to transcriptional changes related to cell differentiation. But what about direct epigenetic changes?๐ค 4/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Strikingly, we observed that at the transcriptomic level the PRC2-depleted showed increased expression of genes typically expressed monocytic-dendritic progenitors (e.g., CDCA7, CDK6), and decreased expression of genes expressed in mature monocytes (e.g., ITGAM, S100A12)๐ฉธ. 3/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
We generated a PRC2-depleted model by heterozygously targeting the catalytic component EZH2โ๏ธin OCI-AML2 cells๐งซ. We then extensively characterized these cells by RNA-Seq, ATAC-Seq, CUT&RUN and Hi-C. 2/17
09.09.2025 13:30 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
ICREA Research Professor at IRB Barcelona. Working on computational cancer genomics. Leading @bbglab.bsky.social
http://bbglab.irbbarcelona.org
Nucleic Acids Research (NAR), from Oxford University Press, publishes the results of leading-edge research into physical, chemical, biochemical and biological aspects of nucleic acids and proteins involved in nucleic acid metabolism and/or interactions
A network for all things chromatin, epigenetic, transcription (and more) research related on the island of Ireland!
https://allirelandchromatinconsortium.ie/
Gene regulation, enhancer, 3D chromatin, transposable elements, cancer epigenetics, inflammation, leukaemia
Professor in Systems Biology & Genetics @EPFL, opinions my own; Single Cell Omics / Gene Regulation / Transcription Factor / Stem Cells / Regulatory Variation / ML / Imaging / Adipose Biology / Microfluidics
https://www.epfl.ch/labs/deplanckelab
Computational biologist interested in deciphering the genomic regulatory code at vib.ai
Professor of Chemical Biology at @Uni_MR. Optochemical tools for controlling biological processes at molecular level. #ChemBioLovers #ChemicalEpigenetics #Photoswitches #Fluorophores #Photosensitizers. Be the Light!โจโจ
He/Him ๐ท๐ด
Car enthusiast, football lover, casual gamer
๐๏ธ F1: CL16, OB81, MV1 || WEC: AFCorse #51, VR46
โฝ Bayern Munchen
๐ฎ The Last of Us, Silent Hill 2
Study genetic conflicts professionally. Try to avoid conflicts in personal life (with mixed results).
Fred Hutch Basic Sciences,
UW Genome Sciences,
HHMI.
Posting in a personal capacity. My posts donโt reflect my employersโ opinions.
Lymphoma+Cellular Therapies fellow at Princess Margaret Cancer Centre Toronto ๐จ๐ฆ/ Physician Scientist in Lymphoma/Chromatin Biology ๐ฎ๐ช
Group Leader - Reader (Assoc. Professor) in AI and Cancer Epigenetics at Blizard Institute, Queen Mary University of London.
#GeneRegulation, #Chromatin, #Epigenetics, #AI, #bioinformatics
https://www.qmul.ac.uk/blizard/all-staff/profiles/radu-zabet.html
Cancer scientist. Gene editing. Dog lover. Australian in the UK.
Group leader at the Centre for Regenerative Medicine (IRR), University of Edinburgh. Exploring the epigenetic mechanisms the control neurodevelopment. Scientist, Dad and lover of all things outdoors!
A closely interacting group of research labs within QMUL investigating the roles of epigenetic mechanisms in development and disease.
https://www.qmul.ac.uk/epigenetics/
TT Prof University clinic Bonn | former postdoc UMN CS | PhD DKFZ | CompBio | CRISPR screening | Data analysis | Networks
We construct systematic key datasets and analytical and visualization tools to accelerate precision cancer medicine
Explore the data: https://depmap.org/portal/
Nature Genetics is a monthly journal publishing high impact research in genetics and genomics. Part of @natureportfolio.bsky.social
Repost/like=interesting/relevant, not necessarily endorsement.
Associate Professor | Functional Genomics | UMass Chan Medical School
Assistant Professor Instituto Superior Tรฉcnico (IST) and INESC-ID
https://web.tecnico.ulisboa.pt/emanuel.v.goncalves/